文献速递脑血管病

COVID-19感染对缺血性卒中患者结局的影响

Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke.
PubMed 文献 · Stroke · 2021-08-30

这项在西班牙加泰罗尼亚开展的前瞻性多中心队列研究,连续纳入2020年3月中旬至5月中旬发病48小时内的急性缺血性卒中且病前mRS 0–3分的患者,比较合并与不合并COVID-19者的卒中严重度、3个月功能结局和死亡。结果显示COVID-19组基线NIHSS更高、3个月死亡率更高,多变量分析中COVID-19是死亡的独立危险因素,但功能结局两组相当。

要点

  • 合并COVID-19的缺血性卒中患者基线卒中严重度更高。
  • COVID-19感染与3个月死亡风险升高独立相关。
  • 多变量分析未显示COVID-19增加不良功能结局概率。

核心结论

  • 合并COVID-19的缺血性卒中患者卒中更严重且死亡率更高,但功能结局与无COVID-19者相当。

研究设计与样本

  • 西班牙加泰罗尼亚前瞻性、观察性、多中心队列研究,2020年3月中旬至5月中旬连续招募。
  • 纳入发病48小时内急性缺血性卒中且病前mRS 0–3分的患者,共评估701例,其中91例(13%)合并COVID-19。

主要发现

  • COVID-19组基线NIHSS中位数8(3–18),非COVID-19组6(2–14),P=0.049。
  • 良好功能结局比例在COVID-19组为33.7%,非COVID-19组为47%。
  • 3个月死亡率在COVID-19组为39.3%,非COVID-19组为16.1%。
  • 多变量logistic回归中COVID-19感染是死亡的危险因素,风险比3.14(95%CI 2.10–4.71),P<0.001。
  • 多变量logistic回归分析显示COVID-19感染未增加不良功能结局的概率。

临床怎么用

  • 对合并COVID-19的缺血性卒中患者应认识到其卒中更重、死亡风险更高,加强监护与救治。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: We evaluated whether stroke severity, functional outcome, and mortality are different in patients with ischemic stroke with or without coronavirus disease 2019 (COVID-19) infection. METHODS: A prospective, observational, multicentre cohort study in Catalonia, Spain. Recruitment was consecutive from mid-March to mid-May 2020. Patients had an acute ischemic stroke within 48 hours and a previous modified Rankin Scale (mRS) score of 0 to 3. We collected demographic data, vascular risk factors, prior mRS score, National Institutes of Health Stroke Scale score, rate of reperfusion therapies, logistics, and metrics. Primary end point was functional outcome at 3 months. Favourable outcome was defined depending on the previous mRS score. Secondary outcome was mortality at 3 months. We performed mRS shift and multivariable analyses. RESULTS: We evaluated 701 patients (mean age 72.3±13.3 years, 60.5% men) and 91 (13%) had COVID-19 infection. Median baseline National Institutes of Health Stroke Scale score was higher in patients with COVID-19 compared with patients without COVID-19 (8 [3-18] versus 6 [2-14], P=0.049). Proportion of patients with a favourable functional outcome was 33.7% in the COVID-19 and 47% in the non-COVID-19 group. However, after a multivariable logistic regression analysis, COVID-19 infection did not increase the probability of unfavourable functional outcome. Mortality rate was 39.3% among patients with COVID-19 and 16.1% in the non-COVID-19 group. In the multivariable logistic regression analysis, COVID-19 infection was a risk factor for mortality (hazard ratio, 3.14 [95% CI, 2.10-4.71]; P<0.001). CONCLUSIONS: Patients with ischemic stroke and COVID-19 infection have more severe strokes and a higher mortality than patients with stroke without COVID-19 infection. However, functional outcome is comparable in both groups.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Martí-Fàbregas J, Guisado-Alonso D, Delgado-Mederos R, et al. Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke. Stroke. 2021. PMID: 34455823. doi:10.1161/STROKEAHA.121.034883

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。